Format

Send to

Choose Destination
See comment in PubMed Commons below
Otolaryngol Head Neck Surg. 2009 Jan;140(1):120-3. doi: 10.1016/j.otohns.2008.10.026.

OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result.

Author information

  • 1Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Korea.

Abstract

INTRODUCTION:

Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present study, the authors retrospectively reviewed the long-term treatment results of picibanil sclerotherapy.

MATERIALS AND METHODS:

Fifty-five lymphangioma patients who underwent picibanil sclerotherapy were enrolled. Data about initial and long-term response, recurrence, and excision rate were collected.

RESULTS:

Initial response rates were 83.5 percent and long-term response rates were 76.3 percent.

CONCLUSION:

Initial and the long-term response rate were equally good for lymphangioma.

PMID:
19130974
DOI:
10.1016/j.otohns.2008.10.026
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center